Erik Buntinx
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
-
- Pharmacological Receptor Mechanisms and Effects 2
- Receptor Mechanisms and Signaling 2
-
- Treatment of Major Depression 3
- Co-authors
- Thomas E. Schläepfer (3 shared papers)Alex McConnachie (1 shared paper)Simon Vermeire (1 shared paper)Maya Hites (1 shared paper)Ping Li (2 shared papers)Alan Wade (1 shared paper)Charissa Borja-Tabora (2 shared papers)Kurt Audenaert (3 shared papers)
- Journals
- European Neuropsychopharmacology (2 papers)Vaccine (2 papers)Nuclear Medicine Communications (1 paper)European Psychiatry (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Erik Buntinx
10 papers receiving 45 citations
Peers
Comparison fields: 5 of 32
- Biological Psychiatry 2
- Infectious Diseases 14
- Pharmacology 10
- Small Animals 4
- Endocrine and Autonomic Systems 3
Countries citing papers authored by Erik Buntinx
This map shows the geographic impact of Erik Buntinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Buntinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Buntinx more than expected).
Fields of papers citing papers by Erik Buntinx
This network shows the impact of papers produced by Erik Buntinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Buntinx. The network helps show where Erik Buntinx may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Buntinx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 11 | |
| 2 | 2011 | 10 | |
| 3 | 2023 | 10 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2010 | 2 | |
| 7 | 2025 | 1 | |
| 8 | Preclinical and clinical evidence for the efficacy of pipamperone in augmenting the antidepressant effects of the SSRI citalopram | 2008 | 1 |
| 9 | 2011 | 1 | |
| 10 | 2008 | 1 |
About Erik Buntinx
Erik Buntinx is a scholar working on Molecular Biology, Pharmacology, Infectious Diseases, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 47 indexed citations. Recurring topics across this work include Treatment of Major Depression (3 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Receptor Mechanisms and Signaling (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Vaccine Coverage and Hesitancy (1 paper), Tryptophan and brain disorders (1 paper) and Fullerene Chemistry and Applications (1 paper). The work is most often cited by research in Biological Psychiatry (2 citations), Infectious Diseases (14 citations), Pharmacology (10 citations), Small Animals (4 citations) and Endocrine and Autonomic Systems (3 citations). Erik Buntinx has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Thomas E. Schläepfer, Alex McConnachie, Simon Vermeire, Maya Hites, Ping Li, Alan Wade, Charissa Borja-Tabora, Kurt Audenaert, Edison Alberto and Alan F. Schatzberg. Their work appears in journals such as European Neuropsychopharmacology, Vaccine, Nuclear Medicine Communications, European Psychiatry and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.